Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage
NCT01180192 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2011-02-14
Summary
In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during the first and second stages of labor. Enhancing oxygen delivery to myometrium through additional inhaled oxygen may improve uterine contractions. Therefore, it is reasonable to consider that oxygen inhalation may promote myometrial contraction and prevent postpartum haemorrhage (PPH) due to uterine atony. The tendency for the uterus to relax in women encountering respiratory problems immediately after cesarean section under general anaesthesia further strengthened this theory.
The aim of this study was to evaluate the effectiveness of oxygen inhalation immediately after vaginal delivery on blood loss. The investigators hypothesized that inhaled oxygen helps to maintain uterine retraction during immediate postpartum period and hence reduces vaginal blood loss.
Conditions
- Postpartum Hemorrhage
Interventions
- DRUG
-
oxygen
either 8 L/minute O2 via face mask for 2 hours
Sponsors & Collaborators
-
Erzincan Military Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-05-31
- Completion
- 2010-09-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery
NCT03755531 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia
NCT04711317 ·Status: COMPLETED ·Phase: NA
-
Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section
NCT05083910 ·Status: COMPLETED ·Phase: NA
-
Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
NCT03852797 ·Status: COMPLETED ·Phase: NA
-
Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage
NCT03578263 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
NCT02079558 ·Status: COMPLETED ·Phase: PHASE2
-
The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery
NCT03967171 ·Status: COMPLETED ·Phase: NA
-
Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
NCT04089176 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Impact of "Natural" Cesarean Delivery on Peripartum Maternal Blood Loss.
NCT02768142 ·Status: COMPLETED ·Phase: NA
-
Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients
NCT03904446 ·Status: COMPLETED ·Phase: PHASE4
-
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
NCT02229513 ·Status: COMPLETED ·Phase: NA
-
Perioperative Warming Measures in Cesarean Delivery
NCT05015582 ·Status: TERMINATED ·Phase: NA
-
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
NCT01252342 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
NCT03651882 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Maternal and Neonatal Oxygenation
NCT01530971 ·Status: COMPLETED ·Phase: PHASE3
-
Oxytocin to Decrease Blood Loss During Cesarean Section
NCT00891150 ·Status: COMPLETED ·Phase: NA
-
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356 ·Status: COMPLETED ·Phase: NA
-
Uterotonics Using to Reduce Bleeding at Cesarean Section
NCT02562300 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Dosing at Planned Cesarean Section and Anemia
NCT03361124 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oxytocin Pharmacokinetics and Pharmacodynamics
NCT05488457 ·Status: RECRUITING ·Phase: PHASE2
-
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
NCT05333731 ·Status: UNKNOWN
-
Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
NCT01932060 ·Status: COMPLETED ·Phase: PHASE3
-
The Oxygenation of the Brain During Caesarean Section
NCT01509521 ·Status: COMPLETED ·Phase: PHASE4
-
Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection
NCT00670020 ·Status: COMPLETED ·Phase: NA
-
Comparative Study Between Oxytocin Infusion Before and After Placental Delivery on Blood Loss During and After Cesarean Delivery .
NCT06889155 ·Status: COMPLETED ·Phase: NA